CIK 0001054102
- Non-accelerated filer
- Smaller reporting company
INTERPACE BIOSCIENCES, INC.
Sign in to watch- Ticker
- IDXG
- Exchange
- OTC
- Industry
- Surgical & Medical Instruments & Apparatus
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 222919486
- Phone
- +1 412-224-6100
- Business address
- WATERVIEW PLAZA, SUITE 310, 2001 ROUTE 46, PARSIPPANY, NJ, 07054
- Former names
- Interpace Diagnostics Group, Inc., PDI INC, PROFESSIONAL DETAILING INC
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Reading 83 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2010-11-16 | Drazner Howard President, Pharmakon | Option exercise | +405 | $10.65 | $4K | 24,284 |
| 2010-11-16 | Drazner Howard President, Pharmakon | Option exercise | +1,070 | $10.65 | $11K | 25,354 |
| 2010-11-16 | Drazner Howard President, Pharmakon | Option exercise | +1,516 | $10.65 | $16K | 26,870 |
| 2010-11-16 | Drazner Howard President, Pharmakon | Option exercise · Stock Appreciation Rights | −5,936 | $9.52 | $57K | 37,814 |
| 2010-11-16 | Drazner Howard President, Pharmakon | Option exercise · Stock Appreciation Rights | −6,067 | $7.73 | $47K | 31,747 |
| 2010-11-16 | Drazner Howard President, Pharmakon | Option exercise · Stock Appreciation Rights | −5,273 | $5.89 | $31K | 26,474 |
| 2010-06-03 | Belle Gerald P. Director | Grant or award | +7,585 | $7.91 | $60K | 33,403 |
| 2010-06-03 | STOVER JACK E Director | Grant or award | +5,689 | $7.91 | $45K | 31,164 |
| 2010-06-03 | SULLIVAN STEPHEN J Director | Grant or award | +5,689 | $7.91 | $45K | 31,614 |
| 2010-06-03 | VECSI JAN MARTENS Director | Grant or award | +5,689 | $7.91 | $45K | 46,764 |
| 2010-06-03 | RYAN FRANK J Director | Grant or award | +5,689 | $7.91 | $45K | 37,164 |
| 2010-06-03 | LUBATKIN VERONICA Director | Grant or award | +5,689 | $7.91 | $45K | 31,970 |
| 2010-06-03 | FEDERSPIEL JOHN Director | Grant or award | +5,689 | $7.91 | $45K | 34,164 |
| 2010-03-01 | Smith Jeffrey Edward CFO | Grant or award | +18,887 | $5.03 | $95K | 150,811 |
| 2010-03-01 | Smith Jeffrey Edward CFO | Grant or award · Stock Apprecation Rights | +38,153 | 137,175 | ||
| 2010-03-01 | Drazner Howard President, Pharmakon | Grant or award | +4,970 | $5.03 | $25K | 25,612 |
| 2010-03-01 | Drazner Howard President, Pharmakon | Grant or award · Stock Appreciation Rights | +10,040 | 43,750 | ||
| 2010-03-01 | Micali Richard P Senior VP, Sales Services | Grant or award | +11,928 | $5.03 | $60K | 16,928 |
| 2010-03-01 | Micali Richard P Senior VP, Sales Services | Grant or award · Stock Appreciation Rights | +24,096 | 27,096 | ||
| 2010-03-01 | Kerr David E Senior VP Business Development | Grant or award | +8,946 | $5.03 | $45K | 8,946 |
Page 12 of 15 · 297 trades